Trials / Completed
CompletedNCT00163111
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
A Randomized, Open Label, Comparative Multicenter Study Of Voriconazole Versus Conventional Amphotericin B Followed By Fluconazole In The Treatment Of Candidaemia In Non Neutropenic Subjects.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 412 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to investigate the safety and efficacy of voriconazole for the treatment of candidemia in critically ill non-neutropenic patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VFEND® I.V., Oral | |
| DRUG | Conventional amphotericin B | |
| DRUG | Diflucan IV, oral |
Timeline
- Start date
- 1998-09-01
- Completion
- 2003-05-01
- First posted
- 2005-09-13
- Last updated
- 2011-04-26
Source: ClinicalTrials.gov record NCT00163111. Inclusion in this directory is not an endorsement.